Post by Rebrain.

« 𝗧𝗵𝗲𝗿𝗲 𝗶𝘀 𝗲𝗻𝗼𝗿𝗺𝗼𝘂𝘀, 𝘂𝗻𝘁𝗮𝗽𝗽𝗲𝗱 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗲𝗹𝗱 𝗼𝗳 𝗰𝗼𝗺𝗽𝗹𝗲𝘅 𝘀𝘂𝗿𝗴𝗲𝗿𝘆.”, 𝗗𝗮𝘃𝗶𝗱 𝗖𝗮𝘂𝗺𝗮𝗿𝘁𝗶𝗻, 𝗥𝗲𝗯𝗿𝗮𝗶𝗻 Our CEO, David Caumartin, recently shared his insights in an interview with Luxinnovation, discussing the challenges and opportunities of bringing data-driven medical technologies to the Medtech market.  “𝘋𝘰𝘤𝘵𝘰𝘳𝘴 𝘢𝘳𝘦 𝘤𝘰𝘯𝘴𝘵𝘢𝘯𝘵𝘭𝘺 𝘪𝘯𝘷𝘪𝘵𝘦𝘥 𝘵𝘰 𝘵𝘳𝘺 𝘯𝘦𝘸 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴. 𝘐𝘧 𝘺𝘰𝘶 𝘤𝘢𝘯’𝘵 𝘥𝘦𝘮𝘰𝘯𝘴𝘵𝘳𝘢𝘵𝘦 𝘵𝘩𝘢𝘵 𝘺𝘰𝘶 𝘩𝘢𝘷𝘦 𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘳𝘦𝘢𝘭𝘭𝘺 𝘣𝘪𝘨, 𝘵𝘩𝘦𝘺 𝘸𝘪𝘭𝘭 𝘴𝘪𝘮𝘱𝘭𝘺 𝘯𝘰𝘵 𝘭𝘪𝘴𝘵𝘦𝘯.” explains David Caumartin. From regulatory pathways to clinical evidence, adoption, and international growth, the interview explores the key factors behind successful healthtech scaling. A big thank you to Luxinnovation for the opportunity to share our journey and vision for the future of data in healthcare.  👉 Explore the full conversation here: https://lnkd.in/eRdAyxc3